Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns

Shivanand Dharwad, Dominic R.M. Saldanha

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The Candida species are ubiquitous yeasts which are found on many plants and are a part of the normal flora of the alimentary tract of mammals and the mucocutaneous membranes of humans. Those that are a part of the normal flora can invade tissues and cause life-threatening diseases in patients whose cell mediated immunity is decreased by disease or iatrogenic intervention. The accurate species identification of Candida is important for the treatment, as not all species respond to the same treatment and also because of the problem of anti-fungal resistance. The aims of the study were to isolate and identify the Candida species from clinical cases of candidiasis and to determine their anti-fungal susceptibility patterns and the predisposing conditions for candidiasis. A total of 100 Candida isolates from various clinical specimens were identified by speciation on a chromogenic medium, HiChrome Candida differential agar. Susceptibility testing was carried out on 50 Candida isolates by using Amphotericin B, Fluconazole, Itraconazole, Voriconazole and Fluocytosine. Candida albicans was the commonest species which was isolated (47%), followed by Candida tropicalis (30%). The Candida isolates were more susceptible to Amphotericin B (92%) and Fluocytosine (88%). Diabetes mellitus appeared to be the commonest predisposing factor for the Candida infections, followed by indiscriminate drug usage. An increase in the predisposing conditions in recent years has resulted in an increasing incidence of Candida infections. Therefore, the species level identification of the Candida isolates, along with their anti-fungal susceptibility patterns can greatly influence the treatment options for the clinician and may have an impact on the patient care also.

Original languageEnglish
Pages (from-to)1177-1181
Number of pages5
JournalJournal of Clinical and Diagnostic Research
Volume5
Issue number6
Publication statusPublished - 01-06-2012
Externally publishedYes

Fingerprint

Candida
Candidiasis
Amphotericin B
Iatrogenic Disease
Candida tropicalis
Itraconazole
Chromogenics
Fluconazole
Infection
Candida albicans
Mammals
Cellular Immunity
Causality
Agar
Medical problems
Patient Care
Diabetes Mellitus
Therapeutics
Yeast
Yeasts

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Clinical Biochemistry

Cite this

@article{f85ef135e6814a90aaac44ce88234767,
title = "Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns",
abstract = "The Candida species are ubiquitous yeasts which are found on many plants and are a part of the normal flora of the alimentary tract of mammals and the mucocutaneous membranes of humans. Those that are a part of the normal flora can invade tissues and cause life-threatening diseases in patients whose cell mediated immunity is decreased by disease or iatrogenic intervention. The accurate species identification of Candida is important for the treatment, as not all species respond to the same treatment and also because of the problem of anti-fungal resistance. The aims of the study were to isolate and identify the Candida species from clinical cases of candidiasis and to determine their anti-fungal susceptibility patterns and the predisposing conditions for candidiasis. A total of 100 Candida isolates from various clinical specimens were identified by speciation on a chromogenic medium, HiChrome Candida differential agar. Susceptibility testing was carried out on 50 Candida isolates by using Amphotericin B, Fluconazole, Itraconazole, Voriconazole and Fluocytosine. Candida albicans was the commonest species which was isolated (47{\%}), followed by Candida tropicalis (30{\%}). The Candida isolates were more susceptible to Amphotericin B (92{\%}) and Fluocytosine (88{\%}). Diabetes mellitus appeared to be the commonest predisposing factor for the Candida infections, followed by indiscriminate drug usage. An increase in the predisposing conditions in recent years has resulted in an increasing incidence of Candida infections. Therefore, the species level identification of the Candida isolates, along with their anti-fungal susceptibility patterns can greatly influence the treatment options for the clinician and may have an impact on the patient care also.",
author = "Shivanand Dharwad and Saldanha, {Dominic R.M.}",
year = "2012",
month = "6",
day = "1",
language = "English",
volume = "5",
pages = "1177--1181",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "6",

}

Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns. / Dharwad, Shivanand; Saldanha, Dominic R.M.

In: Journal of Clinical and Diagnostic Research, Vol. 5, No. 6, 01.06.2012, p. 1177-1181.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns

AU - Dharwad, Shivanand

AU - Saldanha, Dominic R.M.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The Candida species are ubiquitous yeasts which are found on many plants and are a part of the normal flora of the alimentary tract of mammals and the mucocutaneous membranes of humans. Those that are a part of the normal flora can invade tissues and cause life-threatening diseases in patients whose cell mediated immunity is decreased by disease or iatrogenic intervention. The accurate species identification of Candida is important for the treatment, as not all species respond to the same treatment and also because of the problem of anti-fungal resistance. The aims of the study were to isolate and identify the Candida species from clinical cases of candidiasis and to determine their anti-fungal susceptibility patterns and the predisposing conditions for candidiasis. A total of 100 Candida isolates from various clinical specimens were identified by speciation on a chromogenic medium, HiChrome Candida differential agar. Susceptibility testing was carried out on 50 Candida isolates by using Amphotericin B, Fluconazole, Itraconazole, Voriconazole and Fluocytosine. Candida albicans was the commonest species which was isolated (47%), followed by Candida tropicalis (30%). The Candida isolates were more susceptible to Amphotericin B (92%) and Fluocytosine (88%). Diabetes mellitus appeared to be the commonest predisposing factor for the Candida infections, followed by indiscriminate drug usage. An increase in the predisposing conditions in recent years has resulted in an increasing incidence of Candida infections. Therefore, the species level identification of the Candida isolates, along with their anti-fungal susceptibility patterns can greatly influence the treatment options for the clinician and may have an impact on the patient care also.

AB - The Candida species are ubiquitous yeasts which are found on many plants and are a part of the normal flora of the alimentary tract of mammals and the mucocutaneous membranes of humans. Those that are a part of the normal flora can invade tissues and cause life-threatening diseases in patients whose cell mediated immunity is decreased by disease or iatrogenic intervention. The accurate species identification of Candida is important for the treatment, as not all species respond to the same treatment and also because of the problem of anti-fungal resistance. The aims of the study were to isolate and identify the Candida species from clinical cases of candidiasis and to determine their anti-fungal susceptibility patterns and the predisposing conditions for candidiasis. A total of 100 Candida isolates from various clinical specimens were identified by speciation on a chromogenic medium, HiChrome Candida differential agar. Susceptibility testing was carried out on 50 Candida isolates by using Amphotericin B, Fluconazole, Itraconazole, Voriconazole and Fluocytosine. Candida albicans was the commonest species which was isolated (47%), followed by Candida tropicalis (30%). The Candida isolates were more susceptible to Amphotericin B (92%) and Fluocytosine (88%). Diabetes mellitus appeared to be the commonest predisposing factor for the Candida infections, followed by indiscriminate drug usage. An increase in the predisposing conditions in recent years has resulted in an increasing incidence of Candida infections. Therefore, the species level identification of the Candida isolates, along with their anti-fungal susceptibility patterns can greatly influence the treatment options for the clinician and may have an impact on the patient care also.

UR - http://www.scopus.com/inward/record.url?scp=84861539464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861539464&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84861539464

VL - 5

SP - 1177

EP - 1181

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 6

ER -